Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
No more attempts to free whale stranded off Germany, officials say - 2Toilet rats? Washington health officials warn of possible rodents in sewer systems after floods
- 3Dominating Your Cash: The Fundamental Manual for Overseeing Individual accounting records
- 4Australia Cracks Down on Gambling Ads as Prediction Markets Like Polymarket Remain Blocked
- 5Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- The most effective method to Pick The Right Speakers
- Creative Tech Contraptions That Will Work on Your Life
- 6 Fun Urban areas For Seniors To Travel
- Find the Techniques for Powerful Review Propensities: Opening Your Scholarly Potential
- Vote in favor of your #1 Kind of Cap
- Unwinding the Starting points of America: An Excursion Through History
- Ski Resorts Universally: A Colder time of year Wonderland Guide
- Moving Wedding Objections for Paramount Functions
- 5 Destinations Where Airfare Is Dropping The Most For Spring 2026, Per Dollar Flight Club Analysis
